Antifibrinolytic Role Of A Bee Venom Serine Protease Inhibitor That Acts As A Plasmin Inhibitor

Young Moo Choo,Kwang Sik Lee,Hyung Joo Yoon,Yuling Qiu,Hu Wan,Mi Ri Sohn,Hung Dae Sohn,Byung Rae Jin
DOI: https://doi.org/10.1371/journal.pone.0032269
IF: 3.7
2012-01-01
PLoS ONE
Abstract:Bee venom is a rich source of pharmacologically active substances. In this study, we identified a bumblebee (Bombus ignitus) venom Kunitz-type serine protease inhibitor (Bi-KTI) that acts as a plasmin inhibitor. Bi-KTI showed no detectable inhibitory effect on factor Xa, thrombin, or tissue plasminogen activator. In contrast, Bi-KTI strongly inhibited plasmin, indicating that it acts as an antifibrinolytic agent; however, this inhibitory ability was two-fold weaker than that of aprotinin. The fibrin(ogen)olytic activities of B. ignitus venom serine protease (Bi-VSP) and plasmin in the presence of Bi-KTI indicate that Bi-KTI targets plasmin more specifically than Bi-VSP. These findings demonstrate a novel mechanism by which bumblebee venom affects the hemostatic system through the antifibrinolytic activity of Bi-KTI and through Bi-VSP-mediated fibrin(ogen) olytic activities, raising interest in Bi-KTI and Bi-VSP as potential clinical agents.
What problem does this paper attempt to address?